Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Chengdu Kanghong Pharm
ISIN CNE1000020C4
|WKN A2DSJX
Market cap (in EUR)
2,484 m
Country
China
Sector
Healthcare
Dividend yield
2.82%
Overview
Description
Chengdu Kanghong Pharmaceutical Group Co., Ltd. engages in the research, development, production and sale of Chinese patent medicines, chemical medicines and biological products. Its products include Conbercept Ophthalmic Injection, Shugan Jieyu Jiaonang, Ganke Shuangqing Jiaonang, Yiqing Jiaonang, Venlafaxine Hydrochloride Capsules, Xuan Maigangu, Aripiprazole, Keluoxin, Danshu Jiaonang, Mosapride Citrate, and Dexzopiclone. The company was founded on October 3, 1996 and is headquartered in Chengdu, China.
Healthcare Biopharmaceuticals Other Biopharmaceuticals China
Financials
Key metrics
| Market capitalisation, EUR | 2,484 m |
| EPS, EUR | 0.14 |
| P/B ratio | 2.0 |
| P/E ratio | 18.3 |
| Dividend yield | 2.82% |
Income statement (2025)
| Revenue, EUR | 561 m |
| Net income, EUR | 143 m |
| Profit margin | 25.56% |
What ETF is Chengdu Kanghong Pharm in?
There are 11 ETFs which contain Chengdu Kanghong Pharm. All of these ETFs are listed in the table below. The ETF with the largest weighting of Chengdu Kanghong Pharm is the VanEck New China UCITS ETF A.
Order fees
Here you can find information about different brokers that allow you to trade stocks. Select your preferred order volume to compare the fees charged by the respective brokers.
Order volume:
| Broker | Rating | Order fee | Stock savings plans | |
|---|---|---|---|---|
 | 0.99 € | 4500 | View offer** | |
 | 0.00 € | 8045 | View offer* | |
 | 1.00 € | 2500 | View offer* | |
 | 0.00 € | 7560 | View offer* | |
 | 9.95 € | 5000 | View offer* |
Source: justETF Research; as of 5/2026. The offers are sorted in the following way: 1. Rating 2. Order fee 3. Number of stock savings plans. The number of stock savings plans is rounded. In addition to the fees charged by online brokers, additional costs may apply. The stated fees are thus exclusive of standard market spreads, commissions, product costs and third-party fees. Please note: No guarantee can be given for the completeness, correctness and accuracy of the content listed. The information on the online brokers' homepages is decisive. Investments in securities involve risks.
*Affiliate link
** Important note: We are part of the Scalable Group since 2021 and are a wholly owned subsidiary of Scalable GmbH. This means that we are economically connected, but operate with editorial independence. Conflicts of interest are avoided because brokers — including Scalable — are evaluated according to uniform, objective criteria. You can view these in our transparent rating system. Ultimately, it’s up to you to decide how and with whom you want to invest.
*Affiliate link
** Important note: We are part of the Scalable Group since 2021 and are a wholly owned subsidiary of Scalable GmbH. This means that we are economically connected, but operate with editorial independence. Conflicts of interest are avoided because brokers — including Scalable — are evaluated according to uniform, objective criteria. You can view these in our transparent rating system. Ultimately, it’s up to you to decide how and with whom you want to invest.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.